PacBio's revolutionary sequencing technologies combine the completeness of long reads with the accuracy of short reads to provide the most comprehensive view of genomes, transcriptomes, and epigenomes.

PacBio Introduces Vega – Illumina’s Competitor in High-Precision Long-Read Sequencing

PacBio has announced the launched of an affordable line of bench-top long-read sequencers at the American Society of Human Genetics...

Genome Editing
AI in Research

Advertise With Us, Download MediaKit or Email us

Research Relevant Stream

  • Arctoris Acquires Eli Lilly ‘Life Science Studio’ Laboratory

    LC Staff | 2024-10-09

  • $50.3 million set-aside by NIH for “multi-omics” for Health and Disease Consortium

    LC Staff | 2024-09-26

  • MoleculeDAO Announces $50K Award for Researchers in Asia for Drug Development | Email ella@molecule.to

    LC Staff | 2024-04-09

  • Illumina Ventures Re-launches refreshed genomics startup accelerator program

    LC Staff | 2024-02-11

  • Research repository arXiv receives $10M for upgrades to its PrePrint Publishing

    LC Staff | 2023-10-20

  • VitaDAO Launches its first company powered by MoleculeDAO NFT-IP – MatrixBio

    LC Staff | 2023-10-09